Radiation Oncology Strategies to Flatten the Curve During the Coronavirus Disease 2019 (COVID-19) Pandemic: Experience From a Large Tertiary Cancer Center.


Journal

Advances in radiation oncology
ISSN: 2452-1094
Titre abrégé: Adv Radiat Oncol
Pays: United States
ID NLM: 101677247

Informations de publication

Date de publication:
Historique:
received: 09 04 2020
revised: 10 04 2020
accepted: 13 04 2020
entrez: 11 8 2020
pubmed: 11 8 2020
medline: 11 8 2020
Statut: epublish

Résumé

During the coronavirus disease 2019 pandemic, minimizing exposure risk for patients with cancer and health care personnel was of utmost importance. Here, we present steps taken to date to flatten the curve at the radiation oncology division of a tertiary cancer center with the goal of mitigating risk of exposure among patients and staff, and optimizing resource utilization. Response to the coronavirus disease 2019 pandemic in this large tertiary referral center included volume reduction, personal protective equipment recommendations, flexible clinic visit interaction types dictated by need and risk reduction, and numerous social distancing strategies. We hope these outlined considerations can assist the wider radiation oncology community as we collectively face this ongoing challenge.

Identifiants

pubmed: 32775771
doi: 10.1016/j.adro.2020.04.038
pii: S2452-1094(20)30140-8
pmc: PMC7240274
doi:

Types de publication

Journal Article

Langues

eng

Pagination

567-572

Informations de copyright

© 2020 The Authors.

Références

J Natl Cancer Inst. 2005 Jun 1;97(11):798-804
pubmed: 15928300
Int J Radiat Oncol Biol Phys. 1981 Dec;7(12):1633-8
pubmed: 6174490
Int J Radiat Oncol Biol Phys. 1980 Jan;6(1):1-9
pubmed: 6154024
Lancet. 2009 Mar 7;373(9666):811-20
pubmed: 19269519
J Clin Oncol. 2012 Nov 1;30(31):3827-33
pubmed: 23008301
Br J Surg. 2006 Oct;93(10):1215-23
pubmed: 16983741
J Clin Oncol. 2009 Jan 1;27(1):16-23
pubmed: 19018080
Int J Radiat Oncol Biol Phys. 1989 Sep;17(3):659-61
pubmed: 2476426
Radiother Oncol. 2020 Jul;148:115
pubmed: 32361023
Oral Oncol. 2015 Oct;51(10):957-62
pubmed: 26282714
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
JAMA. 2019 Dec 3;322(21):2084-2094
pubmed: 31794625
J Clin Oncol. 2004 Mar 1;22(5):801-10
pubmed: 14990635
J Clin Oncol. 2005 Aug 20;23(24):5644-50
pubmed: 16110023
Radiother Oncol. 2005 Nov;77(2):137-42
pubmed: 16260054
Br J Cancer. 2005 Mar 28;92(6):1038-45
pubmed: 15770205
N Engl J Med. 2001 Aug 30;345(9):638-46
pubmed: 11547717

Auteurs

Sonal S Noticewala (SS)

Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Albert C Koong (AC)

Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Elizabeth S Bloom (ES)

Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Seungtaek Choi (S)

Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Gregory Chronowski (G)

Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Robert A Ghafar (RA)

Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

B Ashleigh Guadagnolo (BA)

Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

G Brandon Gunn (GB)

Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Ann Klopp (A)

Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Percy Lee (P)

Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Jing Li (J)

Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Zhongxing Liao (Z)

Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Ethan B Ludmir (EB)

Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Mary Frances McAleer (MF)

Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Quynh-Nhu Nguyen (QN)

Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Matthew S Ning (MS)

Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Ivy J Robinson (IJ)

Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

David I Rosenthal (DI)

Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Shalin J Shah (SJ)

Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Wendy A Woodward (WA)

Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Denise J Zaebst (DJ)

Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Bouthaina S Dabaja (BS)

Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Prajnan Das (P)

Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

Classifications MeSH